Form D · Biotechnology
Light Sciences Oncology Inc
Bellevue, WA · CIK 0001342272
Offering snapshot reported Jan 18, 2019 · SEC filing
- Reported sold
- $2.03M Offering amount: $2.5M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 3, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 18, 2019 | Initial | $2,025,000 | No comparison | 6 | SEC filing |
| Dec 23, 2013 | Initial | $350,000 | No comparison | 8 | SEC filing |
| Jan 23, 2012 | Initial | $1,255,674 | No comparison | 11 | SEC filing |
| Jun 10, 2011 | Initial | $6,256,000 | No comparison | 17 | SEC filing |
| Nov 5, 2009 | Initial | $35,093,823 | No comparison | 17 | SEC filing |
| Aug 20, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 20, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 19, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-330899
Source: Form D, filed Jan 18, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Edward Avedisian | Director |
| Peter Bisgaard | Director |
| James C Chen | Executive |
| Terry Gould | Director |
| S Erik Hagstrom | Executive |
| Jeff Himawan | Director |
| Jeff Himawan, Ph.D. | Director |
| David P Holveck | Director |
| Mitchell Hymowitz | Director |
| Llew Keltner | Director, Executive |
| Llew Keltner, M.D. Ph.D. | Director, Executive |
| Lisa I. Koch Hulle | Executive |
| Dennis Langer | Director |
| Thomas Lavin | Director |
| Robert Littauer | Executive |
| Martin Olin | Director |
| Mortimer Sackler | Director |
| Akbar Seddigh | Director |
| Sy Shi Wang | Executive |
| Craig Watjen | Director |
| Richard K Whitney | Director |
| Frank E. Young | Director |
| Frank E Young, M.D., Ph.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12600 Se 38 Th St. Ste. 111
Bellevue, WA, 98006
Bellevue, WA, 98006